The aim of this randomized double blind trial is to compare the effect of standard treatment with turmeric pomade on healing of diabetic foot ulcer. In this study, 50 diabetic patients having inclusion criteria will be randomly placed in the intervention or control group. The patients in the intervention group will receive turmeric, one applicator daily for a year. The patients in the control group, however, will receive placebo in a similar dose and shape. To evaluate response to treatment, we will consider the grade and diameter of the wound.
General information
Acronym
IRCT registration information
IRCT registration number:IRCT201012315513N1
Registration date:2011-10-09, 1390/07/17
Registration timing:retrospective
Last update:
Update count:0
Registration date
2011-10-09, 1390/07/17
Registrant information
Name
Rahman Khosravi
Name of organization / entity
Tabriz University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 41 1544 1336
Email address
khosravir@tbzmed.ac.ir
Recruitment status
Recruitment complete
Funding source
Tabriz University of Medical Sciences
Expected recruitment start date
2010-06-22, 1389/04/01
Expected recruitment end date
2011-06-22, 1390/04/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparing effect of standard treatment with turmeric pomade on healing of diabetic foot ulcers
Public title
Comparing effect of standard treatment with turmeric pomade on healing of diabetic foot ulcers
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion Criteria: Diabetes types 1 and 2 under insulin therapy; Age between 18-75 years old; Open wound without healing under treatment for more than 2 weeks without response
Exclusion Criteria: Severe heart failure; Cardiac arrhythmia; Pulselessness; Conditions preventing wound healing such as cellulitis, renal failure and dialysis patients, Severe hepatic failure, Immunosuppressive therapy, Radiotherapy, chemotherapy, varicose
Age
From 18 years old to 75 years old
Gender
Both
Phase
2-3
Groups that have been masked
No information
Sample size
Target sample size:
50
Randomization (investigator's opinion)
Randomized
Randomization description
Blinding (investigator's opinion)
Double blinded
Blinding description
Placebo
Used
Assignment
Other
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Tabriz University of Medical Sciences
Street address
Tabriz University of Medical Sciencesو, Golgasht Street, Tabriz, IRAN